Skip to main content

Day: January 29, 2025

PacBio Technology Powers Landmark Multiomic Study Published in Nature Genetics

New sequencing approach resolves the genetic complexity of a rare Mendelian condition MENLO PARK, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leader in high-quality, long-read sequencing, is proud to announce its critical role in a study to be published in Nature Genetics. The study, titled Synchronized long-read genome, methylome, epigenome, and transcriptome for resolving a Mendelian condition, showcases how researchers leveraged PacBio’s advanced sequencing solutions, including the synchronized Fiber-seq and Kinnex (formerly MAS-seq) multiomic approach, to uncover the genetic and molecular basis of a rare and complex Mendelian condition. In collaboration with the University of Washington and the Undiagnosed Diseases Network (UDN), the study applied PacBio’s state-of-the-art Revio™ sequencing system...

Continue reading

Reporting of granting of Tryg shares by senior management

Group CEO Johan Kirstein Brammer has been granted 38,867 Tryg shares for a total amount of DKK 5,686.242.10. Granting of the shares are related to the bonus programme in 2020 and the acquisition of RSA Scandinavia in 2021. Group COO Lars Bonde has been granted 37,813 Tryg shares for a total amount of DKK 5,532,041.90. Granting of the shares are related to the bonus programme in 2020 and the acquisition of RSA Scandinavia in 2021.Attachment08_2025.29.01 Transaction statement

Continue reading

ibex Earns Fifth Great Place to Work® Certification™ in Nicaragua, Recognizing World-Class Workplace Culture and Employee Experience

ibex Earns Fifth Great Place to Work® Certification™ in Nicaraguaibex is proud to be recognized for its outstanding culture and inclusive workplaceMANAGUA, Nicaragua, Jan. 29, 2025 (GLOBE NEWSWIRE) — ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and AI-powered customer engagement technology solutions, is proud to be Certified™ by Great Place to Work® in Nicaragua for the fifth time overall. This prestigious certification recognizes employers who create an outstanding employee experience and is based entirely on what current employees say about their experience working at ibex. The past year has been transformative for ibex Nicaragua, with the business experiencing strong growth. ibex Nicaragua has expanded to more than 2,100 seats and is poised to surpass 2,200 employees....

Continue reading

IPG Photonics to Showcase Innovative Fiber Laser Solutions for Micro-Machining, Cleaning, Scientific, and Advanced Applications at Photonics West 2025

MARLBOROUGH, Mass., Jan. 29, 2025 (GLOBE NEWSWIRE) — IPG Photonics Corporation (NASDAQ: IPGP), the global leader in fiber laser technology, will showcase new and innovative fiber laser solutions at Photonics West, January 28-30, 2025 in San Francisco. The 1,200 square foot booth will display a wide range of laser sources and laser technologies designed to optimize performance in applications including cleaning, cutting, marking, micro-machining, and quantum computing.  Next-Generation High-Power Laser Platform Improves Performance and Power-to-Volume Ratio IPG will present their new YLS-RI fiber laser platform built with an improved internal architecture to maximize performance and ease of integration. Developed as part of the company’s ongoing commitment to innovation, this new high-power laser platform features next-generation...

Continue reading

Intelligent Bio Solutions Adds Quantum TM to 400+ Account Portfolio Utilizing Breakthrough Fingerprint Drug Testing

Quantum Traffic Management transitions from saliva and urine testing to non-invasive, in-house fingerprint sweat-based drug screening Most recent client added to INBS’s portfolio of more than 400 accounts across the globe, as the Company plans entry into the US market in 2025 NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that Quantum Traffic Management (“Quantum TM”), a leading UK-based traffic management provider, has adopted INBS’ Intelligent Fingerprinting Drug Testing Solution across its 10 nationwide sites to increase workplace testing efficiency and safety. With over 30 years of industry experience, Quantum TM operates across the utilities, highways,...

Continue reading

Dynamic Systems Inc. Teams Up with University of Alabama to Beta Test New UHTC System for Advanced Materials Research

Dynamic System’s UHTC ChamberDeveloped for ceramics and composites, the new UHTC system introduced by the creators of Gleeble simulators combines faster heating and cooling with enhanced testing efficiency, which can significantly increase testing throughput.POESTENKILL, N.Y., Jan. 29, 2025 (GLOBE NEWSWIRE) — Dynamic Systems Inc. (DSI), a leading provider of advanced materials testing solutions and a subsidiary of Vishay Precision Group Inc. (VPG), has launched its new standalone Ultra High Temperature Ceramic and Composite (UHTC) system for the development and testing of non-conductive materials, including ceramics. This innovative solution pushes the boundaries of material testing, enabling research and development at temperatures exceeding 2000°C for non-conductive materials, including ceramics. DSI is proud to...

Continue reading

NewLake Capital Partners Announces Tax Characteristics of 2024 Dividends

NEW CANAAN, Conn., Jan. 29, 2025 (GLOBE NEWSWIRE) — NewLake Capital Partners, Inc. (OTCQX: NLCP) (“The Company” or “NewLake”), a leading provider of real estate capital to state-licensed cannabis operators, today announced the tax treatment of its common stock dividends declared in 2024. The information below is provided to assist the Company’s stockholders with tax reporting requirements related to the dividend distribution of taxable income by the Company. Stockholders should receive IRS Form 1099-DIV containing this information from their brokers, transfer agents or other institutions. These tax statements should be reviewed to ensure that they agree with the information provided below. Tax Treatment of Distributions The Federal Income Tax classification of the 2024 dividend distributions on the Company’s common stock, as it...

Continue reading

Adial Pharmaceuticals Announces Positive Clinical Study Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Completion enables the End-of-Phase 2 (EOP2) interaction with the FDA on the design of the Phase 3 program and is expected to facilitate ongoing partnership discussions Adial’s formulation exhibited predictable bioavailability relative to the reference standard; near-micro doses exhibited dose proportionality in pharmacokinetic exposure, and no food effect Safety and tolerability consistent with ondansetron’s extensive human use experience GLEN ALLEN, Va., Jan. 29, 2025 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, announced the completion of a pharmacokinetics (PK) study of AD04, and has made a regulatory submission of...

Continue reading

ES Bancshares, Inc. Announces Fourth Quarter 2024 Results; Continues Trend of Net Interest Margin Expansion and Asset Quality

STATEN ISLAND, N.Y., Jan. 29, 2025 (GLOBE NEWSWIRE) — ES Bancshares, Inc. (OTCQX: ESBS) (the “Company”) the holding company for Empire State Bank, (the “Bank”) today reported net income of $466 thousand, or $0.03 per diluted common share, for the quarter ended December 31, 2024, compared to a net income of $582 thousand or $0.08 per diluted common share for the quarter ended September 30, 2024. Key Quarterly Financial Data 2024 HighlightsPerformance Metrics   4Q24     3Q24     4Q23   •The Cost of Funds for the three months ended December 31, 2024, improved to 3.02% from 3.02% in the prior linked quarter. •For 3 months ended December 31, 2024, the Company’s net interest margin increased to 2.50% compared to 2.30% for the 3 months ended September 30, 2024. •The Company sold $3 million in SBA 7a loan during the quarter, resulting...

Continue reading

Worksport ($WKSP) Initiates Bitcoin (BTC) & Ripple (XRP) Purchases as Part of Strategic Move to Hedge Inflation and Embrace Cryptocurrency Adoption

Following Business Growth, Company Initiates Purchases and Shares Long-Term View  West Seneca, New York, Jan. 29, 2025 (GLOBE NEWSWIRE) — Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a U.S. based manufacturer and innovator of hybrid and clean energy solutions for the light truck, overlanding, and global consumer goods sectors, is pleased to announce it has made initial purchases of Bitcoin (BTC) and Ripple (XRP) as part of a newly established cryptocurrency treasury strategy. Projecting revenue growth, the release of three (3) new products, and approaching cash flow positivity, all within 2025, the Company’s proactive crypto strategy is positioned as a timely complement to global transformations. A Proactive Treasury Approach This week, Worksport has made its initial six-figure purchase of Bitcoin (BTC) and Ripple...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.